Infections Causing Human Cancer: Softcover Edition

ISBN-13: 9783527329779 / Angielski / Miękka / 2010 / 531 str.

Harald zur Hausen;¬Abar;¬Abar

Opis

Infections must be thought as one of the most important, if not the most important, risk factors for cancer development in humans. Approximately 15-20% of all cases of cancer around the world are caused by viruses. The
establishment of a causal relationship between the presence of specific infective agents and certain types of human cancer represents a key step in the development of novel therapeutic and preventive strategies.

In this book, Professor zur Hausen (Nobel Prize in Physiology/Medicine 2008) provides a thorough and comprehensive overview on carcinogenic infective agents -- viruses, bacteria, parasites and protozoons -- as well as their corresponding transforming capacities and mechanisms. The result is an invaluable and instructive reference for all oncologists, microbiologists and molecular biologists working in the area of infections and cancer.

The author was among the first scientists to reveal the cervical cancer-inducing mechanisms of human papilloma viruses and isolated HPV16 and HPV18, and, as early as 1976, published the hypothesis that wart viruses
play a role in the development of this type of cancer.

During the past 35 years, the author of this work and his co–workers initially found Epstein–Barr virus DNA in Burkitt′s lymphomas and nasopharyngeal cancer and made the connection between HPV infection and cervical cancer. It was also during this period and subsequently that scientists all over the world discovered tumor–inducing bacteria, viruses, parasites, and protozoa, opening up entirely new prospects for the prevention and treatment of infection–induced cancer by vaccination.
Adopting a unifying concept and a consistent structure for the individual chapters, Professor zur Hausen provides a thorough and comprehensive overview on cancer–inducing infective agents – viruses, bacteria and parasites – and their corresponding transforming capacities and mechanisms. He does not cover the structure and molecular biology of the agents presented in great detail, but rather concentrates on those aspects that link the respective agents to human oncogenesis. As such, an extensive bibliography after each chapter permits further studies on the subject.

With a chapter on Helicobacter written by James Fox and his colleagues at Harvard University, this is an invaluable and instructive reference for all oncologists, microbiologists and molecular biologists working in the area of infections and cancer.


Harald zur Hausen studied medicine at the Universities of Bonn, Hamburg and Dusseldorf, gaining his MD in 1960. He was a research fellow at the University of Dusseldorf and the Children′s Hospital of Philadelphia, before being appointed assistant professor at the University of Pennsylvania in 1968. He joined the University of Wurzburg one year later, initially as a senior scientist and then as a private lecturer. From 1972 to 1977 he was Professor of Virology at the University of Erlangen–Nurnberg, and then at the University of Freiburg until 1983. Thereafter, he was appointed Scientific Director of the German Cancer Research Center in Heidelberg until his retirement in 2003.
Professor zur Hausen has been a member of various research organizations, academies of science, and scientific boards. He was President of OECI, Vice–Chairman of the German American Academic Council and Vice–President of the Helmholtz Society of German National Research Centers. Among others, he received the Robert Koch Award, the Charles S. Mott Prize of the General Motors Cancer Research Foundation, the Paul Ehrlich and Ludwig Darmstaedter Award, the German Cancer Award, the Prince Mahidol Award of Thailand and the Federal Order of Merit, as well as six honorary degrees in six different countries. He is Editor–in–Chief of the International Journal of Cancer and on the editorial board of several scientific journals and has organized or co–organized a number of international meetings.

Recenzje

"You should consider purchasing it." Lab Times

Spis treści

HISTORICAL REVIEW
The Early Period (1898–1911)
Frustration and Successes (1912–1950)
The Period from 1950 to 1965
A First Human Tumor Virus?
The Difficult 1970s
The Re–emergence of a Concept
THE QUEST FOR CAUSALITY
Infectious Agents as Direct Carcinogens
Infectious Agents as Indirect Carcinogens
TUMORS LINKED TO INFECTIONS –
SOME GENERAL ASPECTS
Tumor Types Linked to Infections
Global Contributions of Infections to Human Cancer
Host Interactions with Potentially Carcinogenic Infections
HERPESVIRUSES AND ONCOGENESIS
Alphaherpesviridae
Betaherpesviridae
Gammaherpesviridae
PAPILLOMAVIRUSES –
A MAJOR CAUSE OF HUMAN CANCERS
Introduction
Concept of Viral Interfering Cascades
Cancers Linked to HPV Infections
Role of Co–factors
Preventive Vaccination
Therapeutic Vaccination
Therapy
HEPADNAVIRUS FAMILY
Hepatitis B Virus
Animal Hepadnaviruses
FLAVIVIRUS FAMILY
Hepatitis C Virus
RETROVIRUS FAMILY
Human T–lymphotropic Retroviruses 1 (HTLV–1)
Human T–lymphotropic Retroviruses 2 (HTLV–2)
Human Endogenous Retroviruses
Gibbon Ape Leukaemia Virus and Simian Sarcoma Virus
OTHER VIRUS INFECTIONS POSSIBLY INVOLVED IN HUMAN CANCERS
Polyomaviruses (JC, BK and SV40)
HELICOBACTER, CHRONIC INFLAMMATION AND CANCER
Discovery, Taxonomy and Genomics
Life Cycle, Specificity, and Virulence Determinants in Cancer Development
Prevention of H. Pylori Induced Cancer
Animal Models
Virulence Determinants of Enterohepatic Helicobacter Spp
Enterohepatic Helicobacter Spp. –
Are they Cocarcinogens?
PARASITES AND HUMAN CANCER
Schistosomiasis
Infection with Liver Flukes (Opisthorchis Viverrini, O. Felineus, Clonorchis Sinensis)
CANCERS WITH A POSSIBLE INFECTIOUS ETIOLOGY
Leukemias and Lymphomas
Human Breast Cancer
Other Human Cancers Possibly Linked to Infectious Events

O autorze

From 1983 until his retirement in 2003, Harald zur Hausen acted as chairman of the management board and scientific director of the German Cancer Research Center in Heidelberg until his retirement in. Previously he worked at a number of different universities in the USA and Germany. Professor zur Hausen has served on a large number of different scientific and policy bodies in many different countries including the European Board of Directors of HUGO, the International Scientific Advisory Committee of the French National Cancer Institute and Vice–Chairman of the German American Academic Council.

In 2008 Professor zur Hausen was awarded the Nobel Prize in Physiology/Medicine for his research on the relationship between infections and cancer. Among his many other awards, he has held the Robert Koch Award, the Charles S. Mott Prize of the General Motors Cancer Research Foundation, the Paul Ehrlich and Ludwig Darmstaedter Award, the German Cancer Award, and the Federal Order of Merit, as well as six honorary degrees and seven visiting professorships.

Blurb

During the past 35 years, the author of this work and his co–workers initially found Epstein–Barr virus DNA in Burkitt′s lymphomas and nasopharyngeal cancer and made the connection between HPV infection and cervical cancer. It was also during this period and subsequently that scientists all over the world discovered tumor–inducing bacteria, viruses, parasites, and protozoa, opening up entirely new prospects for the prevention and treatment of infection–induced cancer by vaccination.
Adopting a unifying concept and a consistent structure for the individual chapters, Professor zur Hausen provides a thorough and comprehensive overview on cancer–inducing infective agents – viruses, bacteria and parasites – and their corresponding transforming capacities and mechanisms. He does not cover the structure and molecular biology of the agents presented in great detail, but rather concentrates on those aspects that link the respective agents to human oncogenesis. As such, an extensive bibliography after each chapter permits further studies on the subject.

With a chapter on Helicobacter written by James Fox and his colleagues at Harvard University, this is an invaluable and instructive reference for all oncologists, microbiologists and molecular biologists working in the area of infections and cancer.


Harald zur Hausen studied medicine at the Universities of Bonn, Hamburg and Düsseldorf, gaining his MD in 1960. He was a research fellow at the University of Düsseldorf and the Children′s Hospital of Philadelphia, before being appointed assistant professor at the University of Pennsylvania in 1968. He joined the University of Würzburg one year later, initially as a senior scientist and then as a private lecturer. From 1972 to 1977 he was Professor of Virology at the University of Erlangen–Nürnberg, and then at the University of Freiburg until 1983. Thereafter, he was appointed Scientific Director of the German Cancer Research Center in Heidelberg until his retirement in 2003.
Professor zur Hausen has been a member of various research organizations, academies of science, and scientific boards. He was President of OECI, Vice–Chairman of the German American Academic Council and Vice–President of the Helmholtz Society of German National Research Centers. Among others, he received the Robert Koch Award, the Charles S. Mott Prize of the General Motors Cancer Research Foundation, the Paul Ehrlich and Ludwig Darmstaedter Award, the German Cancer Award, the Prince Mahidol Award of Thailand and the Federal Order of Merit, as well as six honorary degrees in six different countries. He is Editor–in–Chief of the International Journal of Cancer and on the editorial board of several scientific journals and has organized or co–organized a number of international meetings.